MMRF PRESS RELEASES
The Multiple Myeloma Research Foundation (MMRF) to Host Clinical Insights Patient Symposium in Collaboration with the John Theurer Cancer Center
Educational Symposium Features Presentations and Workshops from Leading Multiple Myeloma Specialists
NORWALK, C.T. and HACKENSACK, N.J. — March 16, 2011
The Multiple Myeloma Research Foundation (MMRF) and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium (MMRC), will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm. This free educational program is for patients and caregivers who want to learn more about treatment options for multiple myeloma.
“As a result of the tremendous progress we have made accelerating the development of multiple myeloma treatments, patients are living longer and have more treatment options,” said Anne Quinn Young, MPH, Vice President of Communications at the MMRF. “MMRF Clinical Insights programs aim to empower patients and their caregivers by arming them with the knowledge they need to optimally manage their disease. We are proud to join our partners at the John Theurer Cancer Center and other renowned institutions to host this important program.”
Leading multiple myeloma experts will highlight the latest information in multiple myeloma diagnosis, treatment options, clinical trials and research. Topics to be discussed include treatment options for newly diagnosed patients, stem cell transplantation, relapsed/refractory disease, clinical trials, supportive care options, and managing bone disease.
“For nearly five years, we have worked closely with the MMRF through the MMRC, a unique research model critical to bringing new treatments to our patients faster,” said David S. Siegel, M.D., Ph.D., Chief, Multiple Myeloma. “We are excited to take our collaboration with the MMRF outside of the clinic by developing content for this educational symposium, which will be a valuable resource for our patients and their loved ones.”
Dr. Siegel and David H. Vesole, M.D., Ph.D., Co-Chief, Multiple Myeloma, John Theurer Cancer Center are serving as the official program co-chairs for this patient symposium. Additional presenters include:
- Jonathan Kaufman, M.D., Assistant Professor, Blood & Marrow Transplantation, Emory University School of Medicine
- Ann McNeill, RN, MSN, APN, Advanced Practice Nurse, Multiple Myeloma, John Theurer Cancer Center at Hackensack University Medical Center
- Nikhil C. Munshi, M.D., Associate Director, Jerome Lipper Multiple Myeloma Center, Dana- Farber Cancer Institute
- G. David Roodman, M.D., Ph.D., Professor of Medicine and Vice Chair for Research, University of Pittsburgh School of Medicine
Following the symposium, attendees will also have the opportunity to participate in special workshop sessions with Dr. Siegel, Dr. Vesole and Ms. McNeill of the John Theurer Cancer Center. Workshop session topics include Multiple Myeloma 101, Maintenance Therapy and Interpreting Test Results.
“With so much exciting research and treatment options emerging, multiple myeloma patients and caregivers often feel overwhelmed,” said Dr. Vesole. “It is our responsibility to keep the multiple myeloma community informed of our progress and how it will impact the management of their disease.”
The symposium will be hosted at the Hilton Short Hills, 41 JFK Parkway, Short Hills, NJ on Saturday, April 2 from 9:00am-3:30pm. This program is free, however, space is limited. Online registration is available at themmrf.org/clinicalinsights. For additional information, special accommodations or meal requests please contact Sara Tyghter at 203.652.0219 or email@example.com.
About Multiple Myeloma
Multiple myeloma is the second most common blood cancer. Multiple myeloma cannot be cured, but new treatments continue to be evaluated in research studies, and substantial improvements in treatment have been made over the past few years, allowing many individuals to live longer, healthier lives with the disease.
About the Multiple Myeloma Research Foundation
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $160 million since its inception to fund nearly 120 laboratories worldwide, including 60 new compounds and approaches in clinical trials and pre-clinical studies and has facilitated 30 clinical trials through its affiliate organization, the Multiple Myeloma Research Consortium (MMRC). As exceptional stewards of its donor’s investments, the MMRF consistently surpasses its peers in fiscal responsibility. For more information about the MMRF, please visit: www.themmrf.org.
About the John Theurer Cancer Center at Hackensack University Medical Center Division of Multiple Myeloma
The John Theurer Cancer Center at Hackensack University Medical Center is New Jersey's largest and most comprehensive cancer center with 14 specialized divisions covering the complete spectrum of cancer care. The Multiple Myeloma Division is one of only a few programs in the United States to offer specialized expertise in the diagnosis, treatment, and management of multiple myeloma, a type of cancer that strikes the blood system.
For nearly five years, the John Theurer Cancer Center has been a member of the Multiple Myeloma Research Consortium (MMRC) - a unique research model that was developed to accelerate the development of novel, cutting-edge multiple myeloma treatments. Thirteen world-renowned academic institutions comprise the MMRC, working together on collaborative research to develop novel and combination treatments for patients with multiple myeloma. For more information please visit jtcancercenter.org.
Senior Associate, Widmeyer Communications